Internal Medicine · Brownfield, TX
NPI
1730101965
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
703 E Felt St
Brownfield, TX, 79316
Phone (806) 627-1955
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
409 services
Medicare patients, 2024
149
Average age 74
Drug cost, 2024
$1.9M
34,946 prescriptions
Company payments, 2025
$486
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul F Chebib was code 99232 (hospital e&m - subsequent), 73 times for 37 patients. In total Paul F Chebib billed 409 services in 26 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 73 | 37 | $54.31 | $3,965 |
| 99285 Emergency Department E&M | Facility | 66 | 60 | $129.34 | $8,537 |
| 99238 Hospital Discharge Management | Facility | 64 | 61 | $55.77 | $3,569 |
| 99284 Emergency Department E&M | Facility | 39 | 39 | $89.29 | $3,482 |
| 93010 Electrocardiogram | Facility | 36 | 33 | $5.96 | $215 |
| 99222 Hospital E&M - Initial | Facility | 34 | 32 | $90.11 | $3,064 |
| 99223 Hospital E&M - Initial | Facility | 32 | 31 | $119.06 | $3,810 |
| 99239 Hospital Discharge Management | Facility | 11 | 11 | $78.84 | $867 |
By year: 2022 $123K for 1,988 services; 2023 $59K for 864 services; 2024 $31K for 409 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul F Chebib prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,654 prescriptions and refills. In total Paul F Chebib wrote 34,946 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,654 | 2,057 | 146 | $12K |
| Atorvastatin Calcium Generic | 1,489 | 1,919 | 167 | $15K |
| Gabapentin Generic | 1,141 | 1,318 | 106 | $12K |
| Amlodipine Besylate Generic | 1,035 | 1,368 | 134 | $5,470 |
| Divalproex Sodium Generic | 1,029 | 1,038 | 75 | $22K |
| Metformin Hcl Generic | 1,014 | 1,328 | 119 | $5,972 |
| Pantoprazole Sodium Generic | 1,007 | 1,331 | 169 | $10K |
| Lisinopril Generic | 968 | 1,336 | 120 | $6,736 |
| Furosemide Generic | 948 | 1,074 | 97 | $4,947 |
| Tamsulosin Hcl Generic | 943 | 1,093 | 89 | $8,368 |
| Metoprolol Tartrate Generic | 940 | 1,039 | 75 | $4,617 |
| Trazodone Hcl Generic | 743 | 782 | 57 | $4,850 |
| Montelukast Sodium Generic | 740 | 938 | 97 | $4,895 |
| Buspirone Hcl Generic | 697 | 719 | 58 | $7,231 |
| Klor-Con M20 Potassium Chloride | 568 | 570 | 40 | $6,359 |
Brand drugs: 3,069 claims; generic drugs: 31,804 claims; opioid claims: 85.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul F Chebib $486 ($486 in general payments such as food, travel and fees) from 7 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $280.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.